The P2X7R-antagonist AFC-5128 ameliorates chronic experimental autoimmune encephalomyelitis in a preventive and therapeutic paradigm

BackgroundMultiple sclerosis (MS) is characterized by chronic inflammation driven by central nervous system (CNS)-resident immune cells such as microglia, especially during the progressive phase of the disease. The P2X7 receptor (P2X7R), a risk protein for MS, is ubiquitously expressed on immune cel...

Descripció completa

Dades bibliogràfiques

Autors principals:	Robert Hoffrogge, Anna Karachunskaya, Neele Heitmann, Steffen Haupeltshofer, Xiomara Pedreiturria, Katharina Klöster, Verian Bader, Konstanze F. Winklhofer, Michael Hamacher, Bert Klebl, Ralf Gold, Klaus Dinkel, Ingo Kleiter, Simon Faissner
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-04-01
Col·lecció:	Frontiers in Immunology
Matèries:	P2X7R progressive multiple sclerosis microglia neuroinflammation neuroprotection
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1554999/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!